Roivant Sciences Ltd. 2025 Q4 - Results - Earnings Call Presentation
Roivant Sciences Ltd. reported its Q4 2025 earnings results, revealing a loss per share of $0.32, which was better than analysts' expectations. However, the company's revenue of $2.52 million represented a significant decline of 66.71% year-over-year and fell short of projections. The earnings call presentation included a slide deck summarizing these results and insights.
- ▪Roivant Sciences Ltd. reported a Q4 2025 loss per share of $0.32, beating expectations by $0.03.
- ▪The company's revenue for the quarter was $2.52 million, which is a 66.71% decrease compared to the previous year.
- ▪The revenue figure missed analysts' expectations by $1.39 million.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4907499-roivant-sciences-ltd-2025-q4-results-earnings-call-presentation"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.